Potent interaction of flavopiridol with MRP1

British Journal of Cancer

Volumn 81, Issue 2, 1999, Pages 269-276

  Hooijberg, J H ^a   Broxterman, H J ^a   Scheffer, G L ^a   Vrasdonk, C ^a   Heijn, M ^a   De Jong, M C ^a   Scheper, R J ^a   Lankelma, J ^a   Pinedo, H M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

(Iso)flavonoids; ATPase; Flavopiridol; MRP1; Multidrug resistance

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CARRIER PROTEIN; DAUNORUBICIN; FLAVOPIRIDOL; MONOCLONAL ANTIBODY; MULTIDRUG RESISTANCE PROTEIN;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACCUMULATION; DRUG POTENCY; DRUG PROTEIN BINDING; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MEMBRANE VESICLE; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATASES; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CELL DIVISION; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FLAVONOIDS; FLOW CYTOMETRY; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PIPERIDINES; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032857482     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690687     Document Type: Article

References (51)

1. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe SI, Itoh N, Shibuya M and Fukami YJ (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262: 5592-5595
2. Bible KC and Kaufmann SH (1947) Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents; the importance of sequence of administration. Cancer Res 57: 3375-3380
3. Bokkenheuser VD, Shackleton CH and Winter J (1987) Hydrolysis of dietary flavonoid glycosides by strains of intestinal bacteroides from humans. Biochem J 248: 953-956
4. Bots W and Saran M (1987) Radical scavenging by flavonoid antioxidants. Free Rad Res Commun 2: 289-294
5. Broxterman HJ, Kuiper CM, Schuurhuis GJ, Tsuruo T, Pinedo HM and Lankelma J (1988) Increase of daunorubicin and vincristine accumulation in multidrug resistant human ovarian carcinoma cells by a monoclonal antibody reacting with P-glycoprotein. Biochem Pharmacol 37: 2389-2393
6. Broxterman HJ, Giaccone G and Lankelma J (1995) Multidrug resistance proteins and other drug transport-related resistance to natural product agents. Curr Opin Oncol 7: 532-540
7. Butler J, Spielberg SP and Schulman JD (1976) Reduction of disulphide containing amines, amino acids, and small peptides. Anal Biochem 75: 674-675
8. Carlson BA, Dubay MM, Sausville EA, Brizuela L and Worland PJ (1996) Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK)2 and CDK4 in human breast carcinoma cells. Cancer Res 56: 2973-2978
9. Chang X, Hou Y and Riordan J (1997) ATPase activity of purified multidrug resistance-associated protein. J Biol Chem 272: 30962-30968
10. Cole SPC and Deeley RG (1998) Multidrug resistance mediated by the ATP binding cassette transporter protein MRP. Bioessays 20: 931-940
11. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewar AJ, Kurz EU, Duncan AM and Deeley RG (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650-1654
12. Cotelle N, Bernier JN, Henichart JP, Catteau JP, Gaydou E and Wallet JC (1992) Seavenger and antioxidant properties of ten synthetic flavones. Free Rad Biol Med 13: 211-219
13. Critchfield JW, Welsh CJ, Phang JM and Yeh GC (1994) Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Biochem Pharmacol 48: 1437-1445
14. Drees M, Dengler WA, Roth T, Abonte H, Mayo J, Malspeís L, Grever M, Sausville EA and Fiebig HH (1997) Flavopiridol (L86-8275): selective anti-tumour activity in vitro and activity in vivo for prostate carcinoma cells. Clin Cancer Res 3: 273-279
15. Feller N, Broxterman HJ, Währer DCR and Pinedo HM (1995) ATP-dependent efflux of calcein by the multidrug resistance protein (MRP); no inhibition by intracellular glutathione depletion. FEBS Letters 368: 385-388
16. Filgueira de Azevedo Jr W, Mueller-Dieckmann HJ, Schulze-Gahmen U, Worland PJ, Sausville E and Kim SH (1996) Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase. Proc Natl Acad Sci USA 93: 2735-2740
17. Flens MJ, Izquierdo MA, Scheffer GL, Fritz JM, Meijer CJLM, Scheper RJ and Zaman GJR (1994) Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug resistant tumour cells by monoclonal antibodies. Cancer Res 54: 4557-4563
18. Fotsis T, Pepper MS, Adlercreutz H, Fleischmann G, Hase T, Montesano R and Schweigerer L (1993) Genistein, a dictary-derived inhibitor of in vitro angiogenesis, Proc Natl Acad Sci USA 90: 2690-2694
19. Glossmann H, Presek P and Eigenbrot E (1981) Quercetin inhibits tyrosine phosphorylation by the cyclic nucleotide-dependent, transforming protein kinase, pp60src. Naunyn-Schmiedeberg Arch Pharmakol 317: 100-102
20. Gottesman MM and Paslan I (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385-427
21. Gugler R, Leschik M and Dengler HJ (1975) Disposition of quercetin in man after single oral and intravenous doses. Eur J Clin Pharmacol 9: 229-234
22. Heijn M, Oude Elferink RPJ and Jansen PLM (1992) ATP-dependent multispecific anion transport system in rat crythrocyte membrane vesicles. Am J Physiol 262: 104-110
23. Heijn M, Hooijberg JH, Scheffer GL, Szabó G, Westerhoff HV and Lankelma J (1997) Anthracyclines modulate multidrug resistance protein (MRP) mediated organic anion transport. Biochim Biophys Acta 1326: 12-22
24. Higgins CF (1992) ABC transporters: fom micro-organisms to man. Annu Rev Cell Biol 8: 67-113
25. Hoffmann J, Doppler W, Jakob A, Maly K, Posch K, Uberall F and Grunicke H (1988) Enhancement of the anti-proliferative effect of cis-diamminedichloroplatinum(II) and nitrogen mustard by inhibitors of protein kinase C. Int J Cancer 42: 382-388
26. Hollman PCH, de Vries JH, van Leeuwen SD, Mengelers MJ and Katan MB (1995) Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am J Clin Nutr 62: 1276-1282
27. Hollman PCH, van Trijp JMP, Buysman MNCP, vander Gaag MS, Mengelers MJB, de Vries JHM and Katan MB (1997) Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Lett 418: 152-156
28. Hooijberg JH, Broxterman HJ, Heijn M, Fles DLA, Lankelma J and Pinedo HM (1997) Modulation by (iso)flavonoids of the ATPase activity of the multidrug resistance protein. FEBS Lett 413: 344-348
29. Jedlitschky G, Leier I, Buchholz U, Center M and Keppler D (1994) ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res 54: 4833-4836
30. Kool M, de Haas M, Scheffer GL, Scheper RJ, van Eijk MJT, Juijn JA, Baas F and Borst P (1997) Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res 57: 3537-3547
31. Krishnamachary N, Ma L, Zheng L, Safa AR and Center MS (1994) Analysis of MRP gene expression and function in HL60 cells isolated for resistance to adriamycin. Oncol Res 6: 119-127
32. Kuchnau J (1976) The flavonoids. A class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet 24: 117-191
33. Lanzetta PA, Alvarez LJ, Reinach PS and Candia OA (1979) An improved assay for nanomole amounts of inorganic phosphate. Anal Biochem 100: 95-97
34. Loe DW, Stewart RK, Massey TE, Deeley RG and Cole SPC (1997) ATP-dependent transport of aflatoxin B-1 and its glutathione conjugates by the product of the Multidrug Resistance Protein (MRP) gene. Mol Pharmacol 51: 1034-1041
35. Loe DW, Deeley RG and Cole SPC (1998) Characterization of vincristine transport by the MRP 190 000 multidrug resistance protein (MRP) - evidence for cotransport with reduced glutathione. Cancer Res 58: 5130-5136
36. Losiewicz MD, Carlson BA, Kaur G, Sausville EA and Worland PJ (1996) Potent inhibition of cdc2 kinase activity by the flavonoid L86-8275. Biochem Biophys Res Common 201: 589-595
37. Ljumbimov E, Lan LB, Pashinsky I, Ayesh S and Stein WD (1995) Saturation reversal of the multidrug pump using many reversers in low-dose combinations. Anti Cancer Drugs 6: 727-735
38. Markovits J, Linassier C, Fossé P, Couprie J, Pierre J, Jacquemin-Sablon Saucier J.-M, Le Pecq J-B and Larsen AK (1989) Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res 49: 5111-5117
39. Müller M, Meijer C, Zaman GJR, Borst P, Scheper RJ, Mulder NH, de Vries EGE and Jansen PLM (1994) Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc Natl Acad Sci USA 91: 13033-13037
40. Nooter K, Westerman MA, Flens MJ, Zaman GJR, Scheper RJ, van Wingerden KE. Burger H, Oostrum R, Boersma T, Sonneveld P, Gratema JW, Kok T, Eggermont AMM, Bosman FT and Stoter G (1995) Expression of the multidrug resistance-associated protein (MRP) gene in human cancers. Clin Cancer Res 1: 1301-1310
41. Sedlacek HH, Czech J, Naik R, Kaur G, Worland P, Losiewicz M, Parker B, Carlson B, Smith A, Senderowicz A and Sausville E (1996) Flavopiridol (L86 8275 NSC 649890); a new kinase inhibitor for tumor therapy. Int J Oncol 9: 1143-1168
42. Senderowicz AM, Headlee D, Stinson SF, Lush RM, Kalil N, Villalba L, Hill K, Steinberg SM, Figg WD, Tompkins A, Arbuck SG and Sausville EA (1998) Phase I trial of continuous infusion of flavopiridol, a novel cyclin dependent kinase inhibitor, in patients with refractory neoplasms. J Clin Oncol 16: 2986-2999
43. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82: 1107-1112
44. Srivastava AK (1985) Inhibition of phosphorylase kinase, and tyrosine protein kinase activities by quercetin. Biochem Biophys Res Comm 131: 1-5
45. Stinson SF, Hill K, Siford TJ, Phillips LR, Daw TW (1998) Determination of flavopiridol (L86 8275; NSC 649890) in human plasma by reversed-phase liquid chromatography with electrochemical detection. Cancer Chemoth Pharmacol 42: 261-265
46. Versantvoort CHM, Broxterman HJ, Pinedo HM, Feller N, Kuiper CM and Lankelma J (1992) Energy-dependent processes involved in reduced drug accumulation in multidrug resistant human lung cancer cell lines without P-glycoprotein expression. Cancer Res 52: 17-23
47. Versantvoort CHM, Schuurhuis GJ, Pinedo HM, Eckman CA, Kuiper CM, Lankelma J and Broxterman HJ (1993) Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells. Br J Cancer 68: 939-946
48. Versantvoort CHM, Broxterman HJ, Lankelma J, Feller N and Pinedo HM (1994) Saturation and inhibition of the ATP-dependent daunorubicin transport in an MRP overexpressing multidrug resistant human small cell lung cancer cell line. Biochem Pharmacol 48: 1129-1136
49. Walgren RA, Walle UK and Walle T (1998) Transport of quercetin and its glycosides across human intestinal epithelial caco 2 cells. Biochem Pharm 55: 1721-1727
50. Zaman GJR, Flens MJ, van Leusden MR, de Haas M, Mülder HS, Lankelma J, Pinedo HM, Scheper RJ, Baas F, Broxterman HJ and Borst P (1994) The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci USA 91: 8822-8826
51. Zaman GJ, Lankelma J, van Tellingen O, Beijnen J, Dekker H, Paulusma C, Oude Elferink RP, Baas F and Borst P (1995) Role of glutathione in the export of compounds from cells by the multidrug resistance-associated protein. Proc Natl Acad Sci USA 92: 7690-7694